Shree Pacetronix Ltd
Incorporated in 1988, Shree Pacetronix Ltd manufactures and exports Implantable Cardiac Pacemakers.
- Market Cap ₹ 54.6 Cr.
- Current Price ₹ 152
- High / Low ₹ 392 / 96.2
- Stock P/E 14.0
- Book Value ₹ 31.1
- Dividend Yield 0.00 %
- ROCE 46.2 %
- ROE 40.6 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 119 to 84.8 days.
- Company's working capital requirements have reduced from 125 days to 96.0 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 24.2%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7.32 | 6.79 | 8.00 | 6.89 | 7.44 | 6.94 | 6.80 | 7.28 | 8.77 | 7.56 | 9.23 | 20.26 | 22.91 | |
6.35 | 5.53 | 6.60 | 5.86 | 6.37 | 6.39 | 5.88 | 6.50 | 7.57 | 6.62 | 7.45 | 14.81 | 16.56 | |
Operating Profit | 0.97 | 1.26 | 1.40 | 1.03 | 1.07 | 0.55 | 0.92 | 0.78 | 1.20 | 0.94 | 1.78 | 5.45 | 6.35 |
OPM % | 13.25% | 18.56% | 17.50% | 14.95% | 14.38% | 7.93% | 13.53% | 10.71% | 13.68% | 12.43% | 19.28% | 26.90% | 27.72% |
0.10 | 0.04 | 0.01 | 0.03 | 0.02 | 0.05 | 0.01 | 0.17 | 0.04 | 0.05 | 0.07 | 0.10 | 0.13 | |
Interest | 0.47 | 0.42 | 0.47 | 0.42 | 0.37 | 0.40 | 0.32 | 0.32 | 0.38 | 0.35 | 0.29 | 0.30 | 0.36 |
Depreciation | 0.59 | 0.61 | 0.60 | 0.76 | 0.77 | 0.65 | 0.42 | 0.38 | 0.51 | 0.51 | 0.50 | 0.63 | 0.74 |
Profit before tax | 0.01 | 0.27 | 0.34 | -0.12 | -0.05 | -0.45 | 0.19 | 0.25 | 0.35 | 0.13 | 1.06 | 4.62 | 5.38 |
Tax % | 100.00% | 33.33% | 32.35% | 58.33% | -60.00% | 26.67% | 31.58% | 44.00% | 31.43% | 61.54% | 26.42% | 29.44% | |
0.00 | 0.17 | 0.23 | -0.06 | -0.09 | -0.32 | 0.13 | 0.14 | 0.24 | 0.05 | 0.78 | 3.26 | 3.89 | |
EPS in Rs | 0.00 | 0.47 | 0.64 | -0.17 | -0.25 | -0.89 | 0.36 | 0.39 | 0.67 | 0.14 | 2.17 | 9.06 | 10.81 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 24% |
3 Years: | 32% |
TTM: | 52% |
Compounded Profit Growth | |
---|---|
10 Years: | 34% |
5 Years: | 90% |
3 Years: | 142% |
TTM: | 143% |
Stock Price CAGR | |
---|---|
10 Years: | 30% |
5 Years: | 64% |
3 Years: | 136% |
1 Year: | 52% |
Return on Equity | |
---|---|
10 Years: | 7% |
5 Years: | 14% |
3 Years: | 21% |
Last Year: | 41% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 |
Reserves | 1.46 | 1.63 | 1.86 | 1.77 | 1.68 | 1.36 | 1.60 | 1.74 | 1.98 | 2.03 | 2.81 | 6.07 | 7.60 |
2.82 | 2.55 | 2.14 | 2.78 | 1.97 | 2.71 | 2.93 | 3.91 | 3.33 | 3.20 | 3.05 | 2.19 | 3.53 | |
1.19 | 1.46 | 1.38 | 0.95 | 1.35 | 1.16 | 1.33 | 1.35 | 2.08 | 2.15 | 2.72 | 4.68 | 5.69 | |
Total Liabilities | 9.07 | 9.24 | 8.98 | 9.10 | 8.60 | 8.83 | 9.46 | 10.60 | 10.99 | 10.98 | 12.18 | 16.54 | 20.42 |
3.78 | 3.56 | 3.42 | 3.13 | 2.55 | 2.02 | 1.88 | 2.40 | 2.47 | 2.69 | 2.56 | 3.12 | 3.71 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.77 | 0.99 | 1.25 | 1.81 | 1.64 | 1.65 | 1.66 | 1.66 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
5.29 | 5.68 | 5.56 | 5.97 | 6.05 | 6.04 | 6.59 | 6.95 | 6.71 | 6.65 | 7.97 | 11.76 | 15.05 | |
Total Assets | 9.07 | 9.24 | 8.98 | 9.10 | 8.60 | 8.83 | 9.46 | 10.60 | 10.99 | 10.98 | 12.18 | 16.54 | 20.42 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.43 | 0.76 | 1.06 | 0.47 | 1.35 | 0.42 | 1.13 | 0.31 | 2.25 | 1.09 | 1.76 | 1.74 | |
0.32 | -0.34 | -0.44 | -0.49 | -0.18 | -0.86 | -0.52 | -1.01 | -1.00 | -0.53 | -1.19 | -1.41 | |
-0.73 | -0.65 | -0.85 | 0.20 | -1.14 | 0.22 | -0.50 | 0.36 | -1.17 | -0.31 | -0.45 | -1.15 | |
Net Cash Flow | 0.02 | -0.23 | -0.23 | 0.18 | 0.03 | -0.22 | 0.10 | -0.34 | 0.08 | 0.25 | 0.12 | -0.82 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 72.30 | 76.33 | 86.23 | 70.99 | 88.31 | 113.08 | 143.32 | 152.92 | 134.01 | 145.81 | 127.73 | 84.85 |
Inventory Days | 237.41 | 597.81 | 443.76 | 670.58 | 359.32 | 243.33 | 301.93 | 276.44 | 216.62 | 272.02 | 194.20 | 157.41 |
Days Payable | 74.29 | 134.16 | 48.46 | 29.71 | 32.67 | 18.86 | 49.65 | 37.10 | 54.15 | 48.57 | 17.55 | 32.22 |
Cash Conversion Cycle | 235.42 | 539.98 | 481.52 | 711.86 | 414.96 | 337.55 | 395.60 | 392.26 | 296.48 | 369.25 | 304.38 | 210.04 |
Working Capital Days | 165.05 | 183.84 | 179.31 | 235.74 | 197.71 | 216.69 | 209.34 | 217.09 | 129.44 | 159.33 | 120.22 | 96.02 |
ROCE % | 5.85% | 8.81% | 10.53% | 3.56% | 4.16% | -0.80% | 6.46% | 5.06% | 7.93% | 5.30% | 14.43% | 46.15% |
Documents
Announcements
- Disclosure As Per Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015 6h
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 23 Mar
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 4 Mar
-
Reply To Clarification On Price Movement Sought By BSE Limited Reference
19 Feb - Dear Sir, With reference to email received on 19 thFebruary, 2024 seeking clarification on the movement in the price of our security at exchange in …
-
Clarification sought from Shree Pacetronix Ltd
16 Feb - Exchange has sought clarification from Shree Pacetronix Ltd on February 16, 2024 with reference to significant movement in price, in order to ensure that investors …
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2008
from bse
Product Profile:[1][2]
Company deals in 3 major products viz, Pacemakers, Pacing Leads, Pacing System which are further bifurcated as: Ventralite 940+/ Tiranga, Pinnacle-8820, Tiranga -302, Pinnacle-R-SSIR-Model-29, Trinity-R, Smart - E, Atrial-J-Bipolar-Lead-3851-VB, Introducer, Zeus -1, Is1 Bipolar Lead 3851 Vb, Screw-in Lead P12, Pace Maker Analyser, Charak DDDR, Indus I SSB, Implantable Cardioverter Pacemaker, Single Chamber Pacemaker, Reuters Pacemakers, Permanent Pacemaker, Medtronic Pacemaker, Pacing System Analyzer